| [1] |
Marcus SM, Heringhausen JE. Depression in childbearing women: when depression complicates pregnancy[J]. Prim Care, 2009, 36(1):151-165.
|
| [2] |
Kessler RC, McGonagle KA, Swartz M, et al. Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence[J]. J Affect Disord, 1993, 29(2-3):85-96.
|
| [3] |
Gavin NI, Gaynes BN, Lohr KN, et al. Perinatal depression: a systematic review of prevalence and incidence[J]. Obstet Gynecol, 2005, 106(5 Pt 1):1071-1083.
|
| [4] |
Bennett HA, Einarson A, Taddio A, et al. Prevalence of depression during pregnancy: systematic review[J]. Obstet Gynecol, 2004, 103(4):698-709.
|
| [5] |
Lancaster CA, Gold KJ, Flynn HA, et al. Risk factors for depressive symptoms during pregnancy: a systematic review[J]. Am J Obstet Gynecol, 2010, 202(1):5-14.
|
| [6] |
Melville JL, Gavin A, Guo Y, et al. Depressive disorders during pregnancy: prevalence and risk factors in a large urban sample[J]. Obstet Gynecol, 2010, 116(5):1064-1070.
|
| [7] |
Reminick A, Cohen S, Einarson A. Managing depression during pregnancy[J]. Womens Health (Lond Engl), 2013, 9(6):527-535.
|
| [8] |
Hanley GE, Oberlander TF. Neurodevelopmental outcomes following prenatal exposure to serotonin reuptake inhibitor antidepressants: a " social teratogen" or moderator of developmental risk[J]. Birth Defects Res A Clin Mol Teratol, 2012, 94(8):651-659.
|
| [9] |
Graignic-Philippe R, Dayan J, Chokron S, et al. Effects of prenatal stress on fetal and child development: a critical literature review[J]. Neurosci Biobehav Rev, 2014, 43:137-162.
|
| [10] |
Glover V. Maternal depression, anxiety and stress during pregnancy and child outcome; what needs to be done[J]. Best Pract Res Clin Obstet Gynaecol, 2014, 28(1):25-35.
|
| [11] |
Grote NK, Bridge JA, Gavin AR, et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction[J]. Arch Gen Psychiatry, 2010, 67(10):1012-1024.
|
| [12] |
Grigoriadis S, VonderPorten EH, Mamisashvili L, et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis[J]. J Clin Psychiatry, 2013, 74(4):e321-e341.
|
| [13] |
Deave T, Heron J, Evans J, et al. The impact of maternal depression in pregnancy on early child development[J]. BJOG, 2008, 115(8):1043-1051.
|
| [14] |
Ryan D, Milis L, Misri N. Depression during pregnancy[J]. Can Fam Physician, 2005, 51:1087-1093.
|
| [15] |
Pearlstein T. Depression during pregnancy[J]. Best Pract Res Clin Obstet Gynaecol, 2015, 29(5):754-764.
|
| [16] |
Sidebottom AC, Harrison PA, Godecker A, et al. Validation of the Patient Health Questionnaire (PHQ)-9 for prenatal depression screening[J]. Arch Womens Ment Health, 2012, 15(5):367-374.
|
| [17] |
Chaudron LH, Wisner KL. Perinatal depression screening: let′s not throw the baby out with the bath water[J]. J Psychosom Res, 2014, 76(6):489-491.
|
| [18] |
Gorman LL, O′Hara MW, Figueiredo B, et al. Adaptation of the structured clinical interview for DSM-IV disorders for assessing depression in women during pregnancy and post-partum across countries and cultures[J]. Br J Psychiatry Suppl, 2004, 46:s17-s23.
|
| [19] |
Stowe ZN, Hostetter AL, Newport DJ. The onset of postpartum depression: Implications for clinical screening in obstetrical and primary care[J]. Am J Obstet Gynecol, 2005, 192(2):522-526.
|
| [20] |
Kim DR, O′Reardon JP, Epperson CN. Guidelines for the management of depression during pregnancy[J]. Curr Psychiatry Rep, 2010, 12(4):279-281.
|
| [21] |
Spinelli MG, Endicott J. Controlled clinical trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women[J]. Am J Psychiatry, 2003, 160(3):555-562.
|
| [22] |
Sockol LE. A systematic review of the efficacy of cognitive behavioral therapy for treating and preventing perinatal depression[J]. J Affect Disord, 2015, 177:7-21.
|
| [23] |
Grote NK, Swartz HA, Geibel SL, et al. A randomized controlled trial of culturally relevant, brief interpersonal psychotherapy for perinatal depression[J]. Psychiatr Serv, 2009, 60(3):313-321.
|
| [24] |
Parry BL. Assessing risk and benefit: to treat or not to treat major depression during pregnancy with antidepressant medication[J]. Am J Psychiatry, 2009, 166(5):512-514.
|
| [25] |
Alwan S, Reefhuis J, Rasmussen SA, et al. Patterns of antidepressant medication use among pregnant women in a United States population[J]. J Clin Pharmacol, 2011, 51(2):264-270.
|
| [26] |
Cooper WO, Willy ME, Pont SJ, et al. Increasing use of antidepressants in pregnancy[J]. Am J Obstet Gynecol, 2007, 196(6):544.e1-5.
|
| [27] |
Wisner KL, Sit DK, Hanusa BH, et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes[J]. Am J Psychiatry, 2009, 166(5):557-566.
|
| [28] |
Hemels ME, Einarson A, Koren G, et al. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis[J]. Ann Pharmacother, 2005, 39(5):803-809.
|
| [29] |
Einarson A, Choi J, Einarson TR, et al. Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database[J]. J Obstet Gynaecol Can, 2009, 31(5):452-456.
|
| [30] |
Ross LE, Grigoriadis S, Mamisashvili L, et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis[J]. JAMA Psychiatry, 2013, 70(4):436-443.
|
| [31] |
Margulis AV, Abou-Ali A, Strazzeri MM, et al. Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD[J]. Pharmacoepidemiol Drug Saf, 2013, 22(9):942-951.
|
| [32] |
Cole JA, Modell JG, Haight BR, et al. Bupropion in pregnancy and the prevalence of congenital malformations[J]. Pharmacoepidemiol Drug Saf, 2007, 16(5):474-484.
|
| [33] |
Einarson A, Pistelli A, DeSantis M, et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy[J]. Am J Psychiatry, 2008, 165(6):749-752.
|
| [34] |
Källén B. Neonate characteristics after maternal use of antidepressants in late pregnancy[J]. Arch Pediatr Adolesc Med, 2004, 158(4):312-316.
|
| [35] |
Jong GW, Einarson T, Koren G, et al. Antidepressant use in pregnancy and persistent pulmonary hypertension of the newborn (PPHN): a systematic review[J]. Reprod Toxicol, 2012, 34(3):293-297.
|
| [36] |
Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications[J]. JAMA, 2005, 293(19):2372-2383.
|
| [37] |
Figueroa R. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring[J]. J Dev Behav Pediatr, 2010, 31(8):641-648.
|
| [38] |
Vigliani M. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists[J]. Obstet Gynecol, 2009, 114(6):1372.
|
| [39] |
Miller LJ. Use of electroconvulsive therapy during pregnancy[J]. Hosp Community Psychiatry, 1994, 45(5):444-450.
|
| [40] |
Wirz-Justice A, Bader A, Frisch U, et al. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression[J]. J Clin Psychiatry, 2011, 72(7):986-993.
|